Home
—
College of Medicine
—
Department of Pharmacology and Experimental Neuroscience
—
Faculty
—
Daniel Monaghan, PhD
Daniel Monaghan, PhD
Education
- PhD in Biological Sciences, University of California, Irvine, 1985
Research Interests
- Development of subtype-selective glutamate receptor antagonists to determine the roles of individual receptors in brain function and brain disorders
- Determine the intracellular signaling pathways by which NMDA receptors regulate neuronal cell function
-
Evaluation of glutamate receptor regulation of neuronal oscillations using electroencephalography
Memberships
- American Soc. Neurochemistry
- American Soc. Pharmacology and Experimental Therapeutics
- International Soc. Neurochemistry
- Society for Neuroscience
Patents
- NMDA receptor blockers for the prevention of atherosclerosis.
- PPDA, a novel NMDA receptor antagonist of unique subtype selectivity.(joint patent between Dr. David Jane, Univ. Bristol and Dan Monaghan)
- N-Methyl-D-aspartate receptor blockers for the prevention of congenital cardiovascular malformations.
Department of Pharmacology and Experimental Neuroscience
Durham Research Center 3052
985800 Nebraska Medical Center
Omaha, NE 68198-5800